SCHEMBL18323581

SCHEMBL18323581

Cc1nnc2cc(C(=O)O)cc(OCCO)n12

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
KDM5A P29375 3/20 0.33
KDM4C Q9H3R0 3/20 0.33
KDM5B Q9UGL1 2/20 0.33
PLA2G2A P14555 1/20 0.33
BRD4 O60885 7/20 0.32
TPMT P51580 1/20 0.32
BRD2 P25440 1/20 0.31
CREBBP Q92793 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.31
GLA P06280 1/20 0.31
KMT2A Q03164 1/20 0.31
GAA P10253 1/20 0.31
DHODH Q02127 1/20 0.30
PLAU P00749 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18323633 0.88 BRD4 (0.38) KDM4EBRD4ALDH1A1MEN1KMT2A
SCHEMBL18323590 0.87 KDM4E (0.39) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL15907125 0.83 RARG (0.34) KDM5AKDM4CKDM5BPLA2G2AMEN1
SCHEMBL18323638 0.81 KDM4E (0.50) KDM4EBRD4KMT2A
SCHEMBL18323585 0.81 KDM5A (0.41) KDM4EKDM5AKDM4CKDM5BTPMT
SCHEMBL18323697 0.75 KDM4E (0.56) KDM4EKDM5AKDM4CKDM5BBRD4
SCHEMBL18323694 0.73 KDM4E (0.39) KDM4EBRD4TPMTALDH1A1HSD17B10
SCHEMBL18323656 0.73 SMN1; SMN2 (0.38) KDM4EBRD4ALDH1A1
SCHEMBL18323577 0.72 KDM4E (0.36) KDM4EKDM5AKDM4CKDM5BBRD4
SCHEMBL10377918 0.72 KDM4E (0.41) KDM4EBRD4TPMTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed